ARCHIVES

NCCN and Pfizer Issue RFP In Renal Cell Carcinoma Or Hematologic Malignancies

This article is from The Cancer Letter archive.

Vol. 39 No. 40 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

FDA News: Avastin Combination Approved In Recurrent Ovarian Cancer

November 14, 2014

Leukemia Society Seeks Applicants for Grants

December 9, 1994

Kimmel Foundation To Donate $1 million for Cancer Research

June 28, 1996

The Cancer Letter Stands By Story

October 30, 1998

ORI Withdraws Requirement For Research Ethics Courses.

February 23, 2001

CPRU Program Gets Basic Concept Approval

October 2, 1987